본문 바로가기
KERD
논문KCI 등재

Role of Pentacyclic Triterpenoids in Chemoprevention and Anticancer Treatment: An Overview on Targets and Underling Mechanisms

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류한의학

초록

The incidences of cancer are continuously increasing worldwide, affecting life of millions of people. Several factors associated with the internal and external environment are responsible for this deadly disease. The key internal determinants like abnormal hormonal regulation, genetic mutations and external determinants such as lifestyle and occupational factors enhances onset of cancer. From the ancient time, plants were remained as the most trusted source of medicine for the treatment of diverse disease conditions. Extensive studies have been performed for the discovery of effective anticancer agent from the plant and still it is going on. Pentacyclic triterpenoids are biologically active phytochemicals having a different range of activities such as anti-inflammatory, hepatoprotective, anti-hypertensive, antiulcerogenic and anti-tumor. These compounds generally contain ursane, oleanane, lupane and friedelane as a chief skeleton of pentacyclic triterpenoids which are generally present in higher plants. Isoprene unit, phytochemical, with good antitumor/anticancer activity is required for the bio-synthesis of pentacyclic triterpenoids. Mechanisms such as cytotoxicity, DNA polymerase inhibition, regulation of apoptosis, change in signal transductions, interfere with angiogenesis and dedifferentiation, antiproliferative activity and metastasis inhibition are might be responsible for their anticancer effect. Present review spotlights diverse targets, mechanisms and pathways of pentacyclic triterpenoids responsible for anticancer effect.

Abstract

The incidences of cancer are continuously increasing worldwide, affecting life of millions of people. Several factors associated with the internal and external environment are responsible for this deadly disease. The key internal determinants like abnormal hormonal regulation, genetic mutations and external determinants such as lifestyle and occupational factors enhances onset of cancer. From the ancient time, plants were remained as the most trusted source of medicine for the treatment of diverse disease conditions. Extensive studies have been performed for the discovery of effective anticancer agent from the plant and still it is going on. Pentacyclic triterpenoids are biologically active phytochemicals having a different range of activities such as anti-inflammatory, hepatoprotective, anti-hypertensive, antiulcerogenic and anti-tumor. These compounds generally contain ursane, oleanane, lupane and friedelane as a chief skeleton of pentacyclic triterpenoids which are generally present in higher plants. Isoprene unit, phytochemical, with good antitumor/anticancer activity is required for the bio-synthesis of pentacyclic triterpenoids. Mechanisms such as cytotoxicity, DNA polymerase inhibition, regulation of apoptosis, change in signal transductions, interfere with angiogenesis and dedifferentiation, antiproliferative activity and metastasis inhibition are might be responsible for their anticancer effect. Present review spotlights diverse targets, mechanisms and pathways of pentacyclic triterpenoids responsible for anticancer effect.

참고문헌 (78)

  1. Loney T, "An analysis of the health status of the United Arab Emirates : the ‘Big 4’public health issues", Global health action, 6, pp.1~8 (2013)
  2. Dhanamani M, "Ethnomedicinal plants for cancer therapy-a review", Hygeia JD Med, 3, pp.1~10 (2011)
  3. Singh MP, "Clinico-epidemiological study of oral squamous cell carcinoma : A tertiary care centre study in North India", J Oral Biol Craniofac Res, 6, pp.32~35 (2016)
  4. Rang HP, "Rang and Dale's Pharmacology: With student consult online access" (2012), Elsevier Health Sciences
  5. Wang FZ, "PF-04691502 triggers cell cycle arrest, apoptosis and inhibits the angiogenesis in hepatocellular carcinoma cells", Toxicol Lett, 220, pp.150~156 (2013)
  6. Niedzwiecki A, "Anticancer Efficacy of Polyphenols and Their Combinations", Nutrients, 8, pp.552~ (2016)
  7. Safarzadeh E, "Herbal medicine as inducers of apoptosis in cancer treatment", Adv Pharm Bull, 4, pp.421~427 (2014)
  8. Fabio GD, "Triterpenoids from Gymnema sylvestre and their pharmacological activities", Molecules, 19, pp.10956~10981 (2014)
  9. Pratheeshkumar P, "Cancer prevention with promising natural products : mechanisms of action and molecular targets", Anticancer Agents Med Chem, 12, pp.1159~1184 (2012)
  10. Shu L, "Phytochemicals : cancer chemoprevention and suppression of tumor onset and metastasis", Cancer Metastasis Rev, 29, pp.483~502 (2010)
  11. Muffler K, "Biotransformation of triterpenes", Process Biochemistry, 46, pp.1~15 (2011)
  12. Martinez A, "Biotransformation of oleanolic and maslinic acids by Rhizomucor miehei", Phytochemistry, 94, pp.229~237 (2013)
  13. Parmar S, "Neuropharmacological effects of triterpenoids", Phytopharmacology, 4, pp.354~372 (2013)
  14. Pollier J, "Oleanolic acid", Phytochemistry, 77, pp.10~15 (2012)
  15. Maia JL, "Oleanolic acid, a pentacyclic triterpene attenuates capsaicin-induced nociception in mice : possible mechanisms", Pharmacol Res, 54, pp.282~286 (2006)
  16. Moreira DLF, "A non-michaelian behavior of the in vitro metabolism of the pentacyclic triterpene alfa and beta amyrins by employing rat liver microsomes", J Pharm Biomed Anal, 84, pp.14~19 (2013)
  17. Csuk R, "Tormentic acid derivatives : synthesis and apoptic activity", Eur J Med Chem, 56, pp.237~245 (2012)
  18. Mandal A, "Synthesis of friedelan triterpenoid analogs with DNA topoisomerase IIα inhibitory activity and their molecular docking studies", Eur J Med Chem, 54, pp.137~143 (2012)
  19. American Cancer Society, "Cancer Facts & Figures 2016" (2016), American Cancer Society
  20. International Agency for Research on Cancer and Cancer Research UK, "World Cancer Factsheet, Cancer Research UK", ~ (2012)
  21. American Cancer Society, "Cancer Facts & Figures 2013" (2013), American Cancer Society
  22. Ali I, "Cancer scenario in India with future perspectives", Cancer Ther, 8, pp.56~70 (2011)
  23. Pittayapan P, "Health Insurance for Cancer Care in Asia : Thailand", Asia Pac J Oncol Nurs, 3, pp.54~ (2016)
  24. Sreedevi A, "Epidemiology of cervical cancer with special focus on India", Int J Womens Health, 7, pp.405~414 (2015)
  25. Dsouza ND, "Projection of cancer incident cases for India-till 2026", Asian Pac J Cancer Prev, 14, pp.4379~4386 (2013)
  26. Dikshit R, "Cancer mortality in India : a nationally representative survey", The Lancet, 379, pp.1807~1816 (2012)
  27. James JT, "Pentacyclic triterpenoids from the medicinal herb, Centella asiatica (L.) Urban", Molecules, 14, pp.3922~3941 (2009)
  28. Laszczyk MN, "Pentacyclic triterpenes of the lupane, oleanane and ursane group as tools in cancer therapy", Planta med, 75, pp.1549~1560 (2009)
  29. Reyes CP, "Activity of lupane triterpenoids from Maytenus species as inhibitors of nitric oxide and prostaglandin E 2", Bioorg Med Chem, 14, pp.1573~1579 (2006)
  30. Yan XJ, "Triterpenoids as reversal agents for anticancer drug resistance treatment", Drug Discov Today, 19, pp.482~488 (2014)
  31. Yan J, "Serratene Triterpenoids from Palhinhaea cernua var. sikkimensis", Chem Pharm Bull(Tokyo), 57, pp.1381~1384 (2009)
  32. Wittayalai S, "Lycophlegmariols A–D : Cytotoxic serratene triterpenoids from the club moss Lycopodium phlegmaria L", Phytochemistry, 76, pp.117~123 (2012)
  33. Feng JH, "Anti-tumor activity of oleanolic, ursolic and glycyrrhetinic acid", The Open Natural Products Journal, 2, pp.48~52 (2009)
  34. Soldi C, "Synthetic derivatives of the α-and β-amyrin triterpenes and their antinociceptive properties", Bioorg Med Chem, 16, pp.3377~3386 (2008)
  35. Kvasnica M, "Synthesis of phthalates of betulinic acid and betulin with cytotoxic activity", Bioorg Med Chem, 13, pp.3447~3454 (2005)
  36. Gauthier C, "Glycosidation of lupane-type triterpenoids as potent in vitro cytotoxic agents", Bioorg Med Chem, 14, pp.6713~6725 (2006)
  37. Patocka J, "Biologically active pentacyclic triterpenes and their current medicine signification", J Appl Biomed, 1, pp.7~12 (2003)
  38. Bishayee A, "Triterpenoids as potential agents for the chemoprevention and therapy of breast cancer", Front Biosci, 16, pp.980~ (2011)
  39. Li ZJ, "Cytotoxic effect of icaritin and its mechanisms in inducing apoptosis in human burkitt lymphoma cell line", Biomed Res Int, pp.1~7 (2014)
  40. Andreeff M, "Holland-Frei Cancer Medicine" (2003), BC Decker
  41. Sharma P, "Immune checkpoint targeting in cancer therapy : toward combination strategies with curative potential", Cell, 161, pp.205~214 (2015)
  42. Wang SR, "Pentacyclic triterpenoids and their saponins with apoptosis-inducing activity", Curr Top Med Chem, 9, pp.1581~1596 (2009)
  43. Janakiram NB, "Chemoprevention of colon carcinogenesis by oleanolic acid and its analog in male F344 rats and modulation of COX-2 and apoptosis in human colon HT-29 cancer cells", Pharm Res, 25, pp.2151~2157 (2008)
  44. Kanda T, "The androgen receptor as an emerging target in hepatocellular carcinoma", J Hepatocell Carcinoma, 2, pp.91~99 (2015)
  45. Fritz WA, "The aryl hydrocarbon receptor(AhR)inhibits vanadate-induced vascular endothelial growth factor(VEGF)production in TRAMP prostates", Carcinogenesis, 29, pp.1077~1082 (2008)
  46. Senese S, "Chemical dissection of the cell cycle: probes for cell biology and anti-cancer drug development", Cell Death Dis, 5, pp.e1462~ (2014)
  47. Lu JJ, "Anti-cancer properties of terpenoids isolated from Rhizoma Curcumae–A review", J Ethnopharmacol, 143, pp.406~411 (2012)
  48. Kim SS, "3-Oxoolean-12-en-27-oic acid isolated from Aceriphyllum rossii induces caspase-8-dependent apoptosis in human promyelocytic leukemia HL-60 cells", Biol Pharm Bull, 32, pp.91~98 (2009)
  49. Youn SH, "Anticancer properties of pomolic acid-induced AMP-activated protein kinase activation in MCF7 human breast cancer cells", Biol Pharm Bull, 35, pp.105~110 (2012)
  50. Sun CC, "Inhibition of angiogenesis involves in anticancer activity of riccardin D, a macrocyclic bisbibenzyl, in human lung carcinoma", Eur J Pharmacol, 667, pp.136~143 (2011)
  51. Harsh M, "Textbook of pathology" (2010), Jaypee Brothers Medical Publishers
  52. Hu Y, "Targeting cancer stem cells : a new therapy to cure cancer patients", Am J Cancer Res, 2, pp.340~356 (2012)
  53. Ebner F, "The role of TP53 and p21 gene polymorphisms in breast cancer biology in a well specified and characterized German cohort", J Cancer Res Clin Oncol, 136, pp.1369~1375 (2010)
  54. Mutai C, "Cytotoxic lupane-type triterpenoids from Acacia mellifera", Phytochemistry, 65, pp.1159~1164 (2004)
  55. Ketron AC, "Phytochemicals as anticancer and chemopreventive topoisomerase II poisons", Phytochem Rev, 13, pp.19~35 (2013)
  56. Sun H, "Structure-activity relationships of oleanane-and ursane-type triterpenoids", Botanical Studies, 47, pp.339~368 (2006)
  57. Chen Y, "Viral carcinogenesis : factors inducing DNA damage and virus integration", Cancers, 6, pp.2155~2186 (2014)
  58. Nath R, "Anticancer and antioxidant activity of croton : a review", Int J Pharm Pharm Sci, 5, pp.63~70 (2013)
  59. Ramachandran S, "Effect of ursolic acid, a triterpenoid antioxidant, on ultraviolet-B radiation-induced cytotoxicity, lipid peroxidation and DNA damage in human lymphocytes", Chem Biol Interact, 176, pp.99~107 (2008)
  60. Furtado RA, "Ursolic acid and oleanolic acid suppress preneoplastic lesions induced by 1, 2-dimethylhydrazine in rat colon", Toxicol Pathol, 36, pp.576~580 (2008)
  61. Shanmugam MK, "Ursolic acid in cancer prevention and treatment : molecular targets, pharmacokinetics and clinical studies", Biochem Pharmacol, 85, pp.1579~1587 (2013)
  62. Lopez-Hortas L, "Recent developments on the extraction and application of ursolic acid. A review", Food Research International, 103, pp.130~149 (2018)
  63. Kangsamaksin T, "Lupeol and stigmasterol suppress tumor angiogenesis and inhibit cholangiocarcinoma growth in mice via downregulation of tumor necrosis factor-α", Plos One, 12, pp.1~16 (2017)
  64. Turan I, "Cytotoxic effect of Rosa canina extract on human colon cancer cells through repression of telomerase expression", Journal of Pharmaceutical Analysis, 8(6), pp.394~399 (2018)
  65. Thoppil RJ, "Terpenoids as potential chemopreventive and therapeutic agents in liver cancer", World J Hepatol, 3, pp.228~249 (2011)
  66. Salminen A, "Terpenoids : natural inhibitors of NF-κB signaling with anti-inflammatory and anticancer potential", Cell Mol Life Sci, 65, pp.2979~2999 (2008)
  67. Satomi Y, "Glycyrrhetinic acid and related compounds induce G1 arrest and apoptosis in human hepatocellular carcinoma HepG2", Anticancer Res, 25, pp.4043~4047 (2005)
  68. Grace-Lynn C, "In vitro antioxidant activity potential of lantadene A, a pentacyclic triterpenoid of Lantana plants", Molecules, 17, pp.11185~11198 (2012)
  69. Patel S, "A weed with multiple utility : Lantana camara", Reviews in Environmental Science and Bio, 2011, pp.10, 341~351
  70. Kaur J, "Antitumor activity of lantadenes in DMBA", TPA induced skin Tumors in mice : expression of transcription factors, 2010, pp.2, 79~90
  71. Sharma M, "Lantadene A-induced apoptosis in human leukemia HL-60 cells", Indian J Pharmacol, 39, pp.140~ (2007)
  72. Wynendaele W, "Angiogenesis : possibilities for therapeutic interventions", Pharm World Sci, 20, pp.225~235 (1998)
  73. Prasad S, "Induction of apoptosis by lupeol and mango extract in mouse prostate and LNCaP cells", Nutr Cancer, 60, pp.120~130 (2008)
  74. Juan ME, "Antiproliferative and apoptosis-inducing effects of maslinic and oleanolic acids, two pentacyclic triterpenes from olives, on HT-29 colon cancer cells", Br J Nutr, 100, pp.36~43 (2008)
  75. Mu X, "Pristimerin, a triterpenoid, inhibits tumor angiogenesis by targeting VEGFR2 activation", Molecules, 17, pp.6854~6868 (2012)
  76. Swain SS, "Production of triterpenoid anti-cancer compound taraxerol in Agrobacterium- transformed root cultures of butterfly pea (Clitoria ternatea L.)", Appl Biochem Biotechnol, 168, pp.487~503 (2012)
  77. Khanal P, "24-Hydroxyursolic acid from the leaves of the Diospyros kaki(Persimmon)induces apoptosis by activation of AMP-activated protein kinase", Planta Med, 76, pp.689~693 (2010)
  78. Neto CC, "Ursolic acid and other pentacyclic triterpenoids: anticancer activities and occurrence in berries. Berries and Cancer Prevention" (2011), Springer

관련 논문AI추천

이 간행물의 다른 논문 (8건)